OR Royalties Inc. (NYSE:OR) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of OR Royalties Inc. (NYSE:OR) have earned an average rating of “Moderate Buy” from the ten research firms that are currently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $46.50.

Several brokerages have commented on OR. Weiss Ratings restated a “buy (b)” rating on shares of OR Royalties in a report on Friday, May 22nd. Royal Bank Of Canada restated an “outperform” rating and set a $56.00 target price on shares of OR Royalties in a report on Friday, April 10th. Zacks Research cut shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. TD Securities reaffirmed a “hold” rating on shares of OR Royalties in a research note on Monday, February 23rd. Finally, Wall Street Zen cut shares of OR Royalties from a “buy” rating to a “hold” rating in a research note on Saturday.

Hedge Funds Weigh In On OR Royalties

Several hedge funds and other institutional investors have recently made changes to their positions in OR. State of Wyoming bought a new position in shares of OR Royalties in the first quarter valued at $28,000. FIL Ltd bought a new position in shares of OR Royalties in the fourth quarter valued at $29,000. Assetmark Inc. bought a new position in shares of OR Royalties in the fourth quarter valued at $36,000. Banque Cantonale Vaudoise bought a new position in shares of OR Royalties in the first quarter valued at $37,000. Finally, Caitlin John LLC bought a new position in shares of OR Royalties in the third quarter valued at $78,000. 68.52% of the stock is owned by institutional investors.

OR Royalties Stock Performance

Shares of OR stock opened at $33.81 on Friday. The company has a market capitalization of $6.34 billion, a P/E ratio of 25.23 and a beta of 0.70. The company’s 50 day moving average price is $38.03 and its two-hundred day moving average price is $38.69. OR Royalties has a 52 week low of $24.76 and a 52 week high of $48.06.

OR Royalties (NYSE:OR) last announced its earnings results on Wednesday, May 6th. The basic materials company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.34 by $0.06. The firm had revenue of $102.83 million for the quarter, compared to the consensus estimate of $103.27 million. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. Analysts forecast that OR Royalties will post 1.4 earnings per share for the current year.

OR Royalties Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.065 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.8%. This is an increase from OR Royalties’s previous quarterly dividend of $0.06. OR Royalties’s dividend payout ratio (DPR) is 16.42%.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.